受强制性开放获取政策约束的文章 - Sylvie Giacchetti了解详情
无法在其他位置公开访问的文章：4 篇
Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international …
F Efficace, PF Innominato, G Bjarnason, C Coens, Y Humblet, S Tumolo, ...
Journal of Clinical Oncology 26 (12), 2020-2026, 2008
强制性开放获取政策： US National Institutes of Health
Repeat hepatectomy for breast cancer liver metastases
A Ruiz, C Castro-Benitez, M Sebagh, S Giacchetti, E Castro-Santa, ...
Annals of surgical oncology 22, 1057-1066, 2015
强制性开放获取政策： Netherlands Organisation for Scientific Research
Predictive profile-nomogram for liver resection for breast cancer metastases: an aggressive approach with promising results
A Ruiz, DA Wicherts, M Sebagh, S Giacchetti, C Castro-Benitez, ...
Annals of surgical oncology 24, 535-545, 2017
强制性开放获取政策： Netherlands Organisation for Scientific Research
Long-term behavioral symptom clusters among survivors of early-stage breast cancer: Development and validation of a predictive model
M Pagliuca, J Havas, E Thomas, Y Drouet, D Soldato, MA Franzoi, ...
JNCI: Journal of the National Cancer Institute 117 (1), 89-102, 2025
强制性开放获取政策： Agence Nationale de la Recherche
可在其他位置公开访问的文章：19 篇
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
CE Geyer Jr, JE Garber, RD Gelber, G Yothers, M Taboada, L Ross, ...
Annals of oncology 33 (12), 1250-1268, 2022
强制性开放获取政策： US National Institutes of Health, National Institute for Health Research, UK
Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer
PF Innominato, C Focan, T Gorlia, T Moreau, C Garufi, J Waterhouse, ...
Cancer research 69 (11), 4700-4707, 2009
强制性开放获取政策： US National Institutes of Health
Sex‐dependent least toxic timing of irinotecan combined with chronomodulated chemotherapy for metastatic colorectal cancer: randomized multicenter EORTC 05011 trial
PF Innominato, A Ballesta, Q Huang, C Focan, P Chollet, A Karaboué, ...
Cancer medicine 9 (12), 4148-4159, 2020
强制性开放获取政策： Cancer Research UK, UK Medical Research Council
Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer
G Bousquet, M El Bouchtaoui, T Sophie, C Leboeuf, C de Bazelaire, ...
Oncotarget 8 (21), 35205, 2017
强制性开放获取政策： National Institute of Health and Medical Research, France
Circadian rest‐activity rhythm as an objective biomarker of patient‐reported outcomes in patients with advanced cancer
PF Innominato, S Komarzynski, OG Palesh, R Dallmann, GA Bjarnason, ...
Cancer medicine 7 (9), 4396-4405, 2018
强制性开放获取政策： US National Institutes of Health, UK Medical Research Council
Surgical resection versus systemic therapy for breast cancer liver metastases: results of a European case matched comparison
A Ruiz, R Van Hillegersberg, S Siesling, C Castro-Benitez, M Sebagh, ...
European journal of cancer 95, 1-10, 2018
强制性开放获取政策： Netherlands Organisation for Scientific Research
Celecoxib with neoadjuvant chemotherapy for breast cancer might worsen outcomes differentially by COX-2 expression and ER status: exploratory analysis of the REMAGUS02 trial
AS Hamy, S Tury, X Wang, J Gao, JY Pierga, S Giacchetti, E Brain, ...
Journal of Clinical Oncology 37 (8), 624-635, 2019
强制性开放获取政策： US National Institutes of Health, National Institute of Health and Medical …
Dosing time dependent in vitro pharmacodynamics of Everolimus despite a defective circadian clock
Y Zhang, S Giacchetti, A Parouchev, E Hadadi, X Li, R Dallmann, ...
Cell Cycle 17 (1), 33-42, 2018
强制性开放获取政策： National Institute of Health and Medical Research, France
Everolimus added to adjuvant endocrine therapy in patients with high-risk hormone receptor–positive, human epidermal growth factor receptor 2–negative primary breast cancer
T Bachelot, P Cottu, S Chabaud, F Dalenc, D Allouache, S Delaloge, ...
Journal of Clinical Oncology 40 (32), 3699-3708, 2022
强制性开放获取政策： Cancer Research UK, National Institute for Health Research, UK, Swiss Cancer …
Unhealthy behaviors after breast cancer: capitalizing on a teachable moment to promote lifestyle improvements
A Di Meglio, AS Gbenou, E Martin, B Pistilli, JA Ligibel, TE Crane, ...
Cancer 127 (15), 2774-2787, 2021
强制性开放获取政策： Agence Nationale de la Recherche, Susan G. Komen
Efficacy and safety of chronomodulated irinotecan, oxaliplatin, 5‐fluorouracil and leucovorin combination as first‐or second‐line treatment against metastatic colorectal cancer …
PF Innominato, A Karaboué, C Focan, P Chollet, S Giacchetti, ...
International Journal of Cancer 148 (10), 2512-2521, 2021
强制性开放获取政策： Cancer Research UK, UK Medical Research Council
Molecular features of untreated breast cancer and initial metastatic event inform clinical decision-making and predict outcome: long-term results of ESOPE, a single-arm …
C Callens, K Driouch, A Boulai, Z Tariq, A Comte, F Berger, L Belin, ...
Genome Medicine 13, 1-15, 2021
强制性开放获取政策： Agence Nationale de la Recherche
TimeTeller: a new tool for precision circadian medicine and cancer prognosis
D Vlachou, GA Bjarnason, S Giacchetti, F Lévi, DA Rand
bioRxiv, 622050, 2019
强制性开放获取政策： UK Biotechnology and Biological Sciences Research Council, Cancer Research …
COX2/PTGS2 expression is predictive of response to neoadjuvant celecoxib in HER2-negative breast cancer patients
P De Cremoux, AS Hamy, J Lehmann-Che, V Scott, B Sigal, MC Mathieu, ...
Anticancer research 38 (3), 1485-1490, 2018
强制性开放获取政策： National Institute of Health and Medical Research, France
Efficacy of everolimus in patients with HR+/HER2-high risk early stage breast cancer
T Bachelot, F Dalenc, S Chabaud, P Cottu, D Allouache, E Brain, ...
Annals of Oncology 32 (4), 574-575, 2021
强制性开放获取政策： Cancer Research UK
Chemotherapy-Related Amenorrhea and Quality of Life Among Premenopausal Women With Breast Cancer
R Kabirian, MA Franzoi, J Havas, C Coutant, O Tredan, C Levy, P Cottu, ...
JAMA Network Open 6 (11), e2343910-e2343910, 2023
强制性开放获取政策： Agence Nationale de la Recherche, AIRC Foundation for Cancer Research in Italy
出版信息和资助信息由计算机程序自动确定